BODI is expected to report earnings to fall 164.24% to -20 cents per share on August 11
Q2'26
Est.
$-0.21
Q1'26
Beat
by $1.69
Q4'25
Beat
by $0.79
Q3'25
Beat
by $0.56
Q2'25
Missed
by $0.80
The last earnings report on May 12 showed earnings per share of 32 cents, beating the estimate of -136 cents. With 11.01K shares outstanding, the current market capitalization sits at 80.85M.
A.I.dvisor tells us that BODI and ANGI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BODI and ANGI's prices will move in lockstep.
BODI in upward trend: price rose above 50-day moving average on July 09, 2026
BODI moved above its 50-day moving average on July 09, 2026 date and that indicates a change from a downward trend to an upward trend. In of 54 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BODI's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 24, 2026. You may want to consider a long position or call options on BODI as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BODI just turned positive on June 23, 2026. Looking at past instances where BODI's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BODI advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BODI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BODI entered a downward trend on June 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BODI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.353) is normal, around the industry mean (10.977). P/E Ratio (15.295) is within average values for comparable stocks, (32.439). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (32.162). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.341) is also within normal values, averaging (69.638).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BODI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Beachbody (BODI) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
